Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN197348 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-PTK2 Protein tyrosine Kinase 2 (PTK2) (Tyr925) antibody
- Antibody type
- Polyclonal
- Description
- Immunoaffinity Chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- Tyr925
- Vial size
- 0.1 mL
- Storage
- Store the antibody (in aliquots) at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling.
p130cas but not paxillin is essential for Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397.
Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase.
Cherubini A, Hofmann G, Pillozzi S, Guasti L, Crociani O, Cilia E, Di Stefano P, Degani S, Balzi M, Olivotto M, Wanke E, Becchetti A, Defilippi P, Wymore R, Arcangeli A
Molecular biology of the cell 2005 Jun;16(6):2972-83
Molecular biology of the cell 2005 Jun;16(6):2972-83
p130cas but not paxillin is essential for Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
Sanders MA, Basson MD
The Journal of biological chemistry 2005 Jun 24;280(25):23516-22
The Journal of biological chemistry 2005 Jun 24;280(25):23516-22
A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397.
Shi Q, Boettiger D
Molecular biology of the cell 2003 Oct;14(10):4306-15
Molecular biology of the cell 2003 Oct;14(10):4306-15
Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase.
Toriumi Y, Hiraoka M, Watanabe M, Yoshida M
FEBS letters 2003 Oct 23;553(3):419-22
FEBS letters 2003 Oct 23;553(3):419-22
No comments: Submit comment
No validations: Submit validation data